Laserfiche WebLink
TABLE 8 <br /> ANALYSIS OF CHROMIUM CONCENTRATIONS AND REDUCTION POTENTIAL <br /> FORMER MARLEY COOLING TOWER SITE <br /> STOCKTON,CALIFORNIA <br /> Current Concentration Concentration Change Concentration Description of Trend for Key Indicator Parameters Potential for <br /> Monitoring (µg/L) Since 2008 has been Further <br /> Oxidation Reduction Recommendation` <br /> Well Total Chromium Total Chromium Below 50µg/L Chromium Iron Manganese Total Organic Carbon Chromium <br /> Sincea Potential Reductionb <br /> Chromium VI Chromium <br /> Injection Area Wells <br /> Below WQO after spike Stable above WQO, Stable above WQO, Decreasing since 2008 Variable,currently <br /> MW-6 6J <0.5 -98% -100% 10/2010 Goal achieved Continue performance monitoring <br /> in 10/2010 slight increase possibly decreasing injections possitive <br /> Above WQO,below Below WQO, Decreasing since 2008 Continue performance monitoring; supplemental <br /> MW-8 320 307 -58% -56% Exceeds Near baseline Decreasing after 2008 Positive Low <br /> baseline injections injections are being considered <br /> injections <br /> Revert to sitewide compliance monitoring <br /> MW-9 <10 <0.5 -85% NM Before 2008 Stable below WQO Stable near baseline Increased since 7/2010 Low Positive Goal achieved d <br /> program <br /> Stable above baseline Revert to sitewide compliance monitoring <br /> MW-101 3J <0.5 -100% -100% 10/2008 Stable below WQO possibly decreasing program Above baseline Low Positive Goal achieved d <br /> MW-102 825 825 -31% -24% Exceeds Stable above WQO Near baseline,possibly Stable above baseline Low Positive Moderate Continue performance monitoring <br /> decreasing <br /> 0 0 1/2011 Recent increase,now Stable above baseline, Spike after 2010 <br /> MW-104(S-2) <10 <0.5 -100% -100% (4/2008) below WQO possibly decreasing Above baseline injections Negative Likely Continue performance monitoring <br /> MW-105 8J <0.5 -99% -100% 4/2008 Stable below WQO Above baseline Above baseline Low to moderate Positive Goal achieved Revert to sitewide compliance monitoringd <br /> program <br /> MW-106 157 157 -69% -69% Exceeds Above WQO,below Near baseline Below WQO. Slight Decreased to baseline Positive Low Continue performance monitoring <br /> baseline increase above baseline <br /> MW-204(S-8) 2,200 2,190 -50% -40% Exceeds Stable above WQO Near baseline Previously increased, Low Positive Low Continue performance monitoring; supplemental <br /> and possibly decreasing injections are being considered <br /> MW-205(S-7) 450 450 -37% -34% Exceeds Stable above WQO Near baseline Baseline(ND) Low Positive Low Continue performance monitoring; supplemental <br /> injections are being considered <br /> Increased after 2010 <br /> 12/2010 Increased after 2010 Increased after 2010 Decreased after 2010 <br /> MW-206 <10 <0.5 -100% -100% (7/2010) Decreased below WQO injections injections injections,and now injections Goal achieved Continue performance monitoring <br /> decreasing <br /> MW-207 29 28.8 -81% -81% 7/2011 Stable below WQO Near baseline Near baseline Low Positive Goal achieved Continue performance monitoring; supplemental <br /> injections are being considered <br /> Above baseline Revert to sitewide compliance monitoring <br /> MW-208 <10 <0.5 -97% -100% Before 2008 Stable below WQO Near baseline decreasing program Variable Positive Goal achieved d <br /> Revert to sitewide compliance monitoring <br /> MW-300 10 9.94 -67% -50% Before 2008 Stable below WQO Near baseline Baseline(ND) Low Positive Goal achieved d <br /> program <br /> MW-301 135 135 -6% -4% Exceeds Stable above WQO Near baseline Baseline(ND) Low Positive Low Continue performance monitoring <br /> 0 o Spiked in 2009, since Revert to sitewide compliance monitoring <br /> MW-303 5J <0.5 -94% -100/o Before 2008 Stable below WQO Near baseline Above baseline decreased program Positive Goal achieved d <br /> Revert to sitewide compliance monitoring <br /> TW-12 3J <0.5 -91% -98% Before 2008 Stable below WQO Above baseline Above baseline Variable,decreasing Positive Goal achieved d <br /> program <br /> 1/2009(Before Revert to sitewide compliance monitoring <br /> TW-14 <10 <0.5 -94% NM 2008) Stable below WQO Above baseline Above baseline Low Positive Goal achieved d <br /> program <br /> 1/2009(Before Decreasing from high Revert to sitewide compliance monitoring <br /> TW-17 <10 <0.5 -98% NM 2008) after injections program Stable below WQO Above baseline Above baseline Positive Goal achieved d <br /> Revert to sitewide compliance monitoring <br /> EW-1 <10 <0.5 -86% NM 5/2008 Stable below WQO Near baseline Above baseline Low Positive Goal achieved d <br /> program <br /> TW-13 3J <0.5 -100% -100% 4/2010 Stable below WQO Above baseline Above baseline Low Positive Goal achieved Continue performance monitoring <br /> (Page 1 of 3) <br />